LIVE WEBINAR | Neuropsychological impacts of COVID-19

As the pandemic continues to infect millions and new variants pose ongoing challenges, this webinar is a must for neurofeedback clinicians and health professionals willing to understand the neuropsychological impacts of COVID-19.

Jay Gunkelman, QEEG Diplomate Emeritus and world-leading brain-scan analyst brings his expertise and wealth of experience from having analysed over 500,000 EEGs to the emerging issue of neuropsychological impacts of COVID-19. He will delve into the pathological mechanisms underpinning the COVID-19 infection and its impacts on the brain, and explain the ACE2 receptor and its role in blood pressure regulation, vascular function and inflammation.

Jay will explain the process of neurofeedback protocol development based on patterns observed in the EEG and discuss key considerations to ensure best practice and treatment success. The webinar will conclude with a Q&A on the presented material and its implications for clinical practice.

PRESENTER: Jay Gunkelman

Jay Gunkelman is one of the top leaders in the field of EEG and QEEG. He has served as president of The International Society for Neurofeedback and Research, as well as a board member of the AAPB and is a past-president of the BSC.

He was the first EEG technologist to be certified in QEEG and was granted Diplomate Emeritus status in 2002. Jay has conducted, published and participated in hundreds of research papers, articles, books and meetings. Co-founder and Chief Science Officer of Brain Science International, he is a worldwide lecturer on the topic of QEEG and phenotype identification of neurological disorders.

PLEASE NOTE: This seminar will be recorded and available on demand via registration. After registering, please click on the green button to access the event which will log you into the event portal. The event portal will contain the live webinar link and post-event recording and supporting presentation files.

LIVE WEBINAR | Neuropsychological impacts of COVID-19​

LIVE WEBINAR | Neuropsychological impacts of COVID-19